It rained innovation awards at JenLab: Celebrating a Year of Innovation at JenLab!

Hey #TechEnthusiasts and #InnovationFans! 

We’re thrilled to share some groundbreaking news that has us dancing in the rain of innovation awards!

🏆 A Resounding Victory: Innovator of the Year 2023!

We’re proud to announce that JenLab GmbH, our phenomenal “Organ Vision” Project Partner, has clinched the title of “Innovator of the Year 2023”! The award ceremony of the German Economy took place on November 17th at the Hilton Hotel on Gendarmenmarkt in Berlin. JenLab emerged victorious, securing not only the prestigious “Innovator of the Year” award but also the largest “Public’s Choice Award” with a participation of over 32,000 voters!

🌐 Beyond Borders: Berlin Brandenburg Innovation Prize Finalist!

Out of 111 competing companies, JenLab proudly stands tall as one of the top 10 finalists for the Berlin Brandenburg Innovation Prize. This recognition solidifies our commitment to pushing the boundaries of innovation, with a vision that extends far beyond borders!

🔍 Shining Bright on the International Stage: Prism Award Finalist!

But wait, there’s more! The International Society for Optics and Photonics has selected JenLab GmbH as a finalist for the 2024 Prism Award in the Biomedical Photonics category. Join us on January 31st at the Photonics West conference in San Francisco, where JenLab will be honored for the impact of our optical technologies on society.

🔬 Unveiling the Future: MPTcompact Tomograph Launch

On November 14, 2023, at the MEDICA meeting in Duesseldorf, JenLab unveiled the latest MPTcompact tomograph with the highest sensitivity, the greatest functionality, and an outstanding lateral resolution of 300 nanometers. This high-tech gem is set to revolutionize the world of medical devices. The MPTcompact is a game-changer! It offers non-invasive optical skin biopsies with subcellular resolution and provides crucial insights into cell metabolism. The applications of this technology span across a spectrum of crucial areas, ranging from early tumor detection, testing drugs in the pharmaceutical industry and exploring anti-aging effects in the cosmetic industry to the significant reduction of reliance on animal studies.

Cheers to a year of innovation, recognition, and gratitude to everyone who joined our incredible journey!


Prof. Dr. Karsten Koenig (CEO of JenLab GmbH) and PD Dr. Aisada Koenig (Director of Applications Development)